| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.24 | 0.07 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.13 | 0.07 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.077 | 0.08 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |